BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6095865)

  • 1. Pharmacologic receptors for the leukotrienes.
    Fleisch JH; Rinkema LE; Marshall WS
    Biochem Pharmacol; 1984 Dec; 33(24):3919-22. PubMed ID: 6095865
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukotriene receptors.
    Bray MA
    Prog Clin Biol Res; 1985; 199():17-28. PubMed ID: 2999820
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of specific leukotriene C4 binding sites on cultured human keratinocytes.
    Muller A; Michel L; Basset-Seguin N; Modat G; Dubertret L; Bonne C
    Br J Dermatol; 1988 Sep; 119(3):275-80. PubMed ID: 2460124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-specific mechanisms for the responses of human leukocytes to leukotrienes.
    Goetzl EJ; Sherman JW; Ratnoff WD; Harvey JP; Eriksson E; Seaman WE; Baud L; Koo CH
    Ann N Y Acad Sci; 1988; 524():345-55. PubMed ID: 2837968
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology and physiology of leukotrienes and their antagonists.
    Barnes N; Evans J; Zakrzewski J; Piper P; Costello J
    Ann N Y Acad Sci; 1988; 524():369-78. PubMed ID: 2837971
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular heterogeneity of leukotriene receptors: correlation of smooth muscle contraction and radioligand binding in guinea-pig lung.
    Mong S; Wu HL; Scott MO; Lewis MA; Clark MA; Weichman BM; Kinzig CM; Gleason JG; Crooke ST
    J Pharmacol Exp Ther; 1985 Aug; 234(2):316-25. PubMed ID: 2991495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of regulation of receptors and signal transduction pathways for the peptidyl leukotrienes.
    Crooke ST; Mong S; Sarau HM; Winkler JD; Vegesna VK
    Ann N Y Acad Sci; 1988; 524():153-61. PubMed ID: 2837951
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of leukotrienes B4 and C4 on bovine aortic endothelial cell proliferation in vitro.
    Modat G; Muller A; Mary A; Grégoire C; Bonne C
    Prostaglandins; 1987 Apr; 33(4):531-8. PubMed ID: 3037607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotrienes as mediators of ischemia and shock.
    Lefer AM
    Biochem Pharmacol; 1986 Jan; 35(2):123-7. PubMed ID: 3002383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
    Hogaboom GK; Mong S; Stadel JM; Crooke ST
    Mol Pharmacol; 1985 Feb; 27(2):236-45. PubMed ID: 2982090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2, leukotriene C4, and platelet-activating factor receptor sites in the brain. Binding parameters and pharmacological studies.
    Dray F; Wisner A; Bommelaer-Bayet MC; Tiberghien C; Gerozissis K; Saadi M; Junier MP; Rougeot C
    Ann N Y Acad Sci; 1989; 559():100-11. PubMed ID: 2549827
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemical mediators of the airway response--2) Receptors of chemical mediators--with special reference to distribution, isolation and analysis].
    Sano Y
    Nihon Rinsho; 1987 Aug; 45(8):1693-9. PubMed ID: 2824880
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization and regulation of prostaglandin and leukotriene receptors: an overview.
    Robertson RP
    Prostaglandins; 1986 Mar; 31(3):395-411. PubMed ID: 3012652
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclass-specific receptors for sulfidopeptide leukotrienes.
    Austen KF; Lewis RA
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():329-32. PubMed ID: 3004142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.
    Buckner CK; Krell RD; Laravuso RB; Coursin DB; Bernstein PR; Will JA
    J Pharmacol Exp Ther; 1986 May; 237(2):558-62. PubMed ID: 3009792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasomotor effects of leukotrienes C4 and D4 on cavian pulmonary artery and aorta. Characterization and mechanisms.
    Sakuma I; Levi R
    Ann N Y Acad Sci; 1988; 524():91-102. PubMed ID: 2898224
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic profile of SK&F 104353, a novel, highly potent and selective peptidoleukotriene antagonist.
    Wasserman MA; Torphy TJ; Hay DW; Muccitelli RM; Tucker SS; Wilson KA; Osborn RR; Vickery-Clark L; Hall RF; Erhard KF
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():532-5. PubMed ID: 2821765
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and pharmacological characterization of the binding of the selective peptide-leukotriene antagonist, 3H-ICI 198,615, to leukotriene D4 receptors in guinea-pig lung membranes.
    Aharony D; Falcone RC; Yee YK; Hesp B; Giles RE; Krell RD
    Ann N Y Acad Sci; 1988; 524():162-80. PubMed ID: 2837952
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular and cellular diversity of the polymorphonuclear leukocyte receptors for leukotrienes.
    Baud L; Goldman DW; Koo CH; Marotti T; Harvey JP; Goetzl EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():163-6. PubMed ID: 2821754
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological evidence for a distinct leukotriene C4 receptor in guinea-pig trachea.
    Snyder DW; Krell RD
    J Pharmacol Exp Ther; 1984 Dec; 231(3):616-22. PubMed ID: 6094796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.